FOXP2 gene and language impairment in schizophrenia: Association and epigenetic studies

BMC Medical Genetics

Volumn 11, Issue 1, 2010, Pages

  Tolosa, Amparo ^a   Sanjuán, Julio ^a,b   Dagnall, Adam M ^c   Moltó, María D ^a,b   Herrero, Neus ^a,b   de Frutos, Rosa ^a,b  

^a UNIVERSITY OF VALENCIA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c WARNEFORD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR FOXP2; FORKHEAD TRANSCRIPTION FACTOR; FOXP2 PROTEIN, HUMAN;

ANATOMICAL VARIATION; ARTICLE; AUDITORY HALLUCINATION; AUTOPSY; CONTROLLED STUDY; CPG ISLAND; DISEASE COURSE; DNA METHYLATION; EPIGENETICS; EXON; FEMALE; GENE FREQUENCY; GENE LOCATION; GENETIC ASSOCIATION; GENETIC SCREENING; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; LANGUAGE DISABILITY; MALE; PROMOTER REGION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; SOUND INTENSITY; SPEECH ANALYSIS; SUBICULUM; TRINUCLEOTIDE REPEAT; COHORT ANALYSIS; GENETIC EPIGENESIS; GENETICS; HALLUCINATION; METABOLISM; PSYCHOLOGICAL RATING SCALE;

COHORT STUDIES; CPG ISLANDS; DNA METHYLATION; EPIGENESIS, GENETIC; EXONS; FORKHEAD TRANSCRIPTION FACTORS; GENOTYPE; HALLUCINATIONS; HUMANS; LANGUAGE DISORDERS; PARAHIPPOCAMPAL GYRUS; POLYMORPHISM, SINGLE NUCLEOTIDE; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA;

EID: 77954803062     PISSN: None     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/1471-2350-11-114     Document Type: Article

References (40)

1. Sabeti PC, Varilly P, Fry B, Lohmueller J, Hostetter E, Cotsapas C, Xie X, Byrne EH, McCarroll SA, Gaudet R, et al. Genome-wide detection and characterization of positive selection in human populations. Nature 2007, 449:913-918. 10.1038/nature06250, 2687721, 17943131.
2. Carrera N, Sanjuan J, Molto MD, Carracedo A, Costas J. Recent adaptive selection at MAOB and ancestral susceptibility to schizophrenia. Am J Med Genet B Neuropsychiatr Genet 2009, 150B:369-374. 10.1002/ajmg.b.30823, 18553363.
3. Crespi B, Summers K, Dorus S. Adaptive evolution of genes underlying schizophrenia. Proc Biol Sci 2007, 274:2801-2810. 10.1098/rspb.2007.0876, 2288689, 17785269.
4. Lo WS, Xu Z, Yu Z, Pun FW, Ng SK, Chen J, Tong KL, Zhao C, Xu X, Tsang SY, et al. Positive selection within the Schizophrenia-associated GABA(A) receptor beta2 gene. PLoS ONE 2007, 2:e462. 10.1371/journal.pone.0000462, 1866178, 17520021.
5. Dean B. Is schizophrenia the price of human central nervous system complexity?. Aust N Z J Psychiatry 2009, 43:13-24. 10.1080/00048670802534416, 19085524.
6. Pearlson GD, Folley BS. Schizophrenia, psychiatric genetics, and Darwinian psychiatry: an evolutionary framework. Schizophr Bull 2008, 34:722-733. 10.1093/schbul/sbm130, 2632450, 18033774.
7. Brune M. Schizophrenia-an evolutionary enigma?. Neurosci Biobehav Rev 2004, 28:41-53. 10.1016/j.neubiorev.2003.10.002, 15036932.
8. Burns J. The social brain hypothesis of schizophrenia. World Psychiatry 2006, 5:77-81. 1525115, 16946939.
9. Crow TJ. Schizophrenia as the price that homo sapiens pays for language: a resolution of the central paradox in the origin of the species. Brain Res Brain Res Rev 2000, 31:118-129. 10.1016/S0165-0173(99)00029-6, 10719140.
10. Khaitovich P, Lockstone HE, Wayland MT, Tsang TM, Jayatilaka SD, Guo AJ, Zhou J, Somel M, Harris LW, Holmes E, et al. Metabolic changes in schizophrenia and human brain evolution. Genome Biol 2008, 9:R124. 10.1186/gb-2008-9-8-r124, 2575514, 18681948.
11. Crow TJ. The 'big bang' theory of the origin of psychosis and the faculty of language. Schizophr Res 2008, 102:31-52. 10.1016/j.schres.2008.03.010, 18502103.
12. Li X, Branch CA, Delisi LE. Language pathway abnormalities in schizophrenia: a review of fMRI and other imaging studies. Curr Opin Psychiatry 2009, 22:131-139. 10.1097/YCO.0b013e328324bc43, 19553866.
13. Lai CS, Fisher SE, Hurst JA, Vargha-Khadem F, Monaco AP. A forkhead-domain gene is mutated in a severe speech and language disorder. Nature 2001, 413:519-523. 10.1038/35097076, 11586359.
14. Vernes SC, Spiteri E, Nicod J, Groszer M, Taylor JM, Davies KE, Geschwind DH, Fisher SE. High-throughput analysis of promoter occupancy reveals direct neural targets of FOXP2, a gene mutated in speech and language disorders. Am J Hum Genet 2007, 81:1232-1250. 10.1086/522238, 2276341, 17999362.
15. Enard W, Przeworski M, Fisher SE, Lai CS, Wiebe V, Kitano T, Monaco AP, Paabo S. Molecular evolution of FOXP2, a gene involved in speech and language. Nature 2002, 418:869-872. 10.1038/nature01025, 12192408.
16. Zhang J, Webb DM, Podlaha O. Accelerated protein evolution and origins of human-specific features: Foxp2 as an example. Genetics 2002, 162:1825-1835. 1462353, 12524352.
17. Fisher SE. Tangled webs: tracing the connections between genes and cognition. Cognition 2006, 101:270-297. 10.1016/j.cognition.2006.04.004, 16764847.
18. MacDermot KD, Bonora E, Sykes N, Coupe AM, Lai CS, Vernes SC, Vargha-Khadem F, McKenzie F, Smith RL, Monaco AP, et al. Identification of FOXP2 truncation as a novel cause of developmental speech and language deficits. Am J Hum Genet 2005, 76:1074-1080. 10.1086/430841, 1196445, 15877281.
19. Newbury DF, Fisher SE, Monaco AP. Recent advances in the genetics of language impairment. Genome Med 2010, 2:6. 10.1186/gm127, 20193051.
20. Vernes SC, Newbury DF, Abrahams BS, Winchester L, Nicod J, Groszer M, Alarcón M, Oliver PL, Davies KE, Geschwind DH, et al. A functional genetic link between distinct developmental language disorders. N Engl J Med 2008, 359:2337-2345. 10.1056/NEJMoa0802828, 2756409, 18987363.
21. Poot M, Beyer V, Schwaab I, Damatova N, Van't Slot R, Prothero J, Holder SE, Haaf T. Disruption of CNTNAP2 and additional structural genome changes in a boy with speech delay and autism spectrum disorder. Neurogenetics 2010, 11:81-89. 10.1007/s10048-009-0205-1, 19582487.
22. Jung SM, Jung BJ, Cho JS, Park JM. FOXP2 gene possibly associated with Korean schizophrenic patients. European Neuropsychopharmacology. The Journal of the European College of Neuropsychopharmacology 2008, 18:S4.
23. Sanjuan J, Tolosa A, Gonzalez JC, Aguilar EJ, Molto MD, Najera C, de Frutos R. FOXP2 polymorphisms in patients with schizophrenia. Schizophr Res 2005, 73:253-256. 10.1016/j.schres.2004.05.012, 15653268.
24. Sanjuan J, Tolosa A, Gonzalez JC, Aguilar EJ, Perez-Tur J, Najera C, Molto MD, de Frutos R. Association between FOXP2 polymorphisms and schizophrenia with auditory hallucinations. Psychiatr Genet 2006, 16:67-72. 10.1097/01.ypg.0000185029.35558.bb, 16538183.
25. Krawiecka M, Goldberg D, Vaughan M. A standardized psychiatric assessment scale for rating chronic psychotic patients. Acta Psychiatr Scand 1977, 55:299-308. 10.1111/j.1600-0447.1977.tb00174.x, 855676.
26. Haddock G, McCarron J, Tarrier N, Faragher EB. Scales to measure dimensions of hallucinations and delusions: the psychotic symptom rating scales (PSYRATS). Psychol Med 1999, 29:879-889. 10.1017/S0033291799008661, 10473315.
27. Covington MA, He C, Brown C, Naci L, McClain JT, Fjordbak BS, Semple J, Brown J. Schizophrenia and the structure of language: the linguist's view. Schizophr Res 2005, 77:85-98. 10.1016/j.schres.2005.01.016, 16005388.
28. Delisi LE. Speech disorder in schizophrenia: review of the literature and exploration of its relation to the uniquely human capacity for language. Schizophr Bull 2001, 27:481-496.
29. McKenna PJ, Oh T. Schizophrenic speech 2005, Cambridge University Press.
30. Watkins KE, Dronkers NF, Vargha-Khadem F. Behavioural analysis of an inherited speech and language disorder: comparison with acquired aphasia. Brain 2002, 125:452-464. 10.1093/brain/awf058, 11872604.
31. Margolis RL, Abraham MR, Gatchell SB, Li SH, Kidwai AS, Breschel TS, Stine OC, Callahan C, McInnis MG, Ross CA. cDNAs with long CAG trinucleotide repeats from human brain. Hum Genet 1997, 100:114-122. 10.1007/s004390050476, 9225980.
32. Bruce HA, Margolis RL. FOXP2: novel exons, splice variants, and CAG repeat length stability. Hum Genet 2002, 111:136-144. 10.1007/s00439-002-0768-5, 12189486.
33. Laroche F, Ramoz N, Leroy S, Fortin C, Rousselot-Paillet B, Philippe A, Colleaux L, Bresson JL, Mogenet A, Golse B, et al. Polymorphisms of coding trinucleotide repeats of homeogenes in neurodevelopmental psychiatric disorders. Psychiatr Genet 2008, 18:295-301. 10.1097/YPG.0b013e3283060fa5, 19018235.
34. Kato C, Petronis A, Okazaki Y, Tochigi M, Umekage T, Sasaki T. Molecular genetic studies of schizophrenia: challenges and insights. Neurosci Res 2002, 43:295-304. 10.1016/S0168-0102(02)00064-0, 12135773.
35. Petronis A. The origin of schizophrenia: genetic thesis, epigenetic antithesis, and resolving synthesis. Biol Psychiatry 2004, 55:965-970. 10.1016/j.biopsych.2004.02.005, 15121478.
36. Mill J, Tang T, Kaminsky Z, Khare T, Yazdanpanah S, Bouchard L, Jia P, Assadzadeh A, Flanagan J, Schumacher A, et al. Epigenomic profiling reveals DNA-methylation changes associated with major psychosis. Am J Hum Genet 2008, 82:696-711. 10.1016/j.ajhg.2008.01.008, 2427301, 18319075.
37. Tsankova N, Renthal W, Kumar A, Nestler EJ. Epigenetic regulation in psychiatric disorders. Nat Rev Neurosci 2007, 8:355-367. 10.1038/nrn2132, 17453016.
38. Schroeder DI, Myers RM. Multiple transcription start sites for FOXP2 with varying cellular specificities. Gene 2008, 413:42-48. 10.1016/j.gene.2008.01.015, 18316164.
39. Vita A, De Peri L, Silenzi C, Dieci M. Brain morphology in first-episode schizophrenia: a meta-analysis of quantitative magnetic resonance imaging studies. Schizophr Res 2006, 82:75-88. 10.1016/j.schres.2005.11.004, 16377156.
40. Boos HB, Aleman A, Cahn W, Hulshoff PH, Kahn RS. Brain volumes in relatives of patients with schizophrenia: a meta-analysis. Arch Gen Psychiatry 2007, 64:297-304. 10.1001/archpsyc.64.3.297, 17339518.